أعرض في EDS

Study in CHC patients comparing three different combination therapies with interferon a-2b (IFN) and ribavirin (rebetol): Weekly PEG-IFN (Peg-intron) versus daily IFN (intron a pen) versus standard regimen of IFN (Intron a pen)

التفاصيل البيبلوغرافية
العنوان:	Study in CHC patients comparing three different combination therapies with interferon a-2b (IFN) and ribavirin (rebetol): Weekly PEG-IFN (Peg-intron) versus daily IFN (intron a pen) versus standard regimen of IFN (Intron a pen)
المؤلفون:	X. De Koninck, P.P. Michielsen, V. Lefèbvre, Nadine Bourgeois, Réginald Brenard, P. Langlet, H. Van Vlierberghe, Liesbeth Bruckers, M. Adler, I. Colle, Yves Horsmans, Jean Henrion
المصدر:	Gastroenterology. 124:A768
بيانات النشر:	Elsevier BV, 2003.
سنة النشر:	2003
مصطلحات موضوعية:	Hepatology, business.industry, Ribavirin, Gastroenterology, Intron, Pharmacology, Virology, chemistry.chemical_compound, Regimen, chemistry, Interferon, PEG ratio, Medicine, business, medicine.drug
تدمد:	0016-5085
DOI:	10.1016/s0016-5085(03)83882-9
URL الوصول:	https://explore.openaire.eu/search/publication?articleId=doi_________::1ebd0c17ddf8b643884b0f8efebc39cc https://doi.org/10.1016/s0016-5085(03)83882-9
Rights:	CLOSED
رقم الانضمام:	edsair.doi...........1ebd0c17ddf8b643884b0f8efebc39cc
قاعدة البيانات:	OpenAIRE

الوصف
تدمد:	00165085
DOI:	10.1016/s0016-5085(03)83882-9